Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001003983> ?p ?o ?g. }
- W2001003983 endingPage "1195" @default.
- W2001003983 startingPage "1195" @default.
- W2001003983 abstract "<h3>Context</h3>Schizophrenic symptoms are linked to a dysfunction of dopamine neurotransmission and the brain reward system. However, it remains unclear whether antipsychotic treatment, which blocks dopamine transmission, improves, alters, or even worsens the reward-related abnormalities.<h3>Objective</h3>To investigate changes in reward-related brain activations in schizophrenia before and after antipsychotic monotherapy with a dopamine D<sub>2</sub>/D<sub>3</sub> antagonist.<h3>Design</h3>Longitudinal cohort study.<h3>Setting</h3>Psychiatric inpatients and outpatients in the Capital Region of Denmark.<h3>Participants</h3>Twenty-three antipsychotic-naive patients with first-episode schizophrenia and 24 healthy controls initially matched on age, sex, and parental socioeconomic status were examined with functional magnetic resonance imaging while playing a variant of the monetary incentive delay task.<h3>Interventions</h3>Patients were treated for 6 weeks with the antipsychotic compound amisulpride. Controls were followed up without treatment.<h3>Main Outcome Measures</h3>Task-related blood oxygen level–dependent activations as measured by functional magnetic resonance imaging before and after antipsychotic treatment.<h3>Results</h3>At baseline, patients, as compared with controls, demonstrated an attenuation of brain activation during reward anticipation in the ventral striatum, bilaterally. After 6 weeks of treatment, patients showed an increase in the anticipation-related functional magnetic resonance imaging signal and were no longer statistically distinguishable from healthy controls. Among the patients, there was a correlation between the improvement of positive symptoms and normalization of reward-related activation. Those who showed the greatest clinical improvement in positive symptoms also showed the greatest increase in reward-related activation after treatment.<h3>Conclusions</h3>To our knowledge, this is the first controlled, longitudinal study of reward disturbances in schizophrenic patients before and after their first antipsychotic treatment. Our results demonstrate that alterations in reward processing are fundamental to the illness and are seen prior to any treatment. Antipsychotic treatment tends to normalize the response of the reward system; this was especially seen in the patients with the most pronounced treatment effect on the positive symptoms.<h3>Trial Registration</h3>clinicaltrials.gov Identifier: NCT01154829." @default.
- W2001003983 created "2016-06-24" @default.
- W2001003983 creator A5025353819 @default.
- W2001003983 creator A5027992573 @default.
- W2001003983 creator A5034030427 @default.
- W2001003983 creator A5037602769 @default.
- W2001003983 creator A5055136911 @default.
- W2001003983 creator A5062126653 @default.
- W2001003983 creator A5064325537 @default.
- W2001003983 creator A5082664965 @default.
- W2001003983 date "2012-12-01" @default.
- W2001003983 modified "2023-10-05" @default.
- W2001003983 title "Improvement of Brain Reward Abnormalities by Antipsychotic Monotherapy in Schizophrenia" @default.
- W2001003983 cites W1660666227 @default.
- W2001003983 cites W1963580478 @default.
- W2001003983 cites W1966618733 @default.
- W2001003983 cites W1971101485 @default.
- W2001003983 cites W1975417628 @default.
- W2001003983 cites W1980311530 @default.
- W2001003983 cites W1991367158 @default.
- W2001003983 cites W1991528023 @default.
- W2001003983 cites W2003505635 @default.
- W2001003983 cites W2010945210 @default.
- W2001003983 cites W2016540784 @default.
- W2001003983 cites W2024370389 @default.
- W2001003983 cites W2026871932 @default.
- W2001003983 cites W2032074381 @default.
- W2001003983 cites W2041053327 @default.
- W2001003983 cites W2046173356 @default.
- W2001003983 cites W2052445433 @default.
- W2001003983 cites W2060039072 @default.
- W2001003983 cites W2063902973 @default.
- W2001003983 cites W2066987713 @default.
- W2001003983 cites W2075675414 @default.
- W2001003983 cites W2075943763 @default.
- W2001003983 cites W2077301822 @default.
- W2001003983 cites W2079767332 @default.
- W2001003983 cites W2079908656 @default.
- W2001003983 cites W2084331056 @default.
- W2001003983 cites W2099576957 @default.
- W2001003983 cites W2101723737 @default.
- W2001003983 cites W2105092774 @default.
- W2001003983 cites W2106827577 @default.
- W2001003983 cites W2111993699 @default.
- W2001003983 cites W2117649346 @default.
- W2001003983 cites W2117726420 @default.
- W2001003983 cites W2119128116 @default.
- W2001003983 cites W2136022845 @default.
- W2001003983 cites W2140606211 @default.
- W2001003983 cites W2145602532 @default.
- W2001003983 cites W2153437292 @default.
- W2001003983 cites W2155554204 @default.
- W2001003983 cites W2158396789 @default.
- W2001003983 cites W2159039084 @default.
- W2001003983 cites W2160695817 @default.
- W2001003983 cites W2163805252 @default.
- W2001003983 cites W2169155487 @default.
- W2001003983 cites W33021784 @default.
- W2001003983 cites W45776812 @default.
- W2001003983 doi "https://doi.org/10.1001/archgenpsychiatry.2012.847" @default.
- W2001003983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22868877" @default.
- W2001003983 hasPublicationYear "2012" @default.
- W2001003983 type Work @default.
- W2001003983 sameAs 2001003983 @default.
- W2001003983 citedByCount "134" @default.
- W2001003983 countsByYear W20010039832013 @default.
- W2001003983 countsByYear W20010039832014 @default.
- W2001003983 countsByYear W20010039832015 @default.
- W2001003983 countsByYear W20010039832016 @default.
- W2001003983 countsByYear W20010039832017 @default.
- W2001003983 countsByYear W20010039832018 @default.
- W2001003983 countsByYear W20010039832019 @default.
- W2001003983 countsByYear W20010039832020 @default.
- W2001003983 countsByYear W20010039832021 @default.
- W2001003983 countsByYear W20010039832022 @default.
- W2001003983 countsByYear W20010039832023 @default.
- W2001003983 crossrefType "journal-article" @default.
- W2001003983 hasAuthorship W2001003983A5025353819 @default.
- W2001003983 hasAuthorship W2001003983A5027992573 @default.
- W2001003983 hasAuthorship W2001003983A5034030427 @default.
- W2001003983 hasAuthorship W2001003983A5037602769 @default.
- W2001003983 hasAuthorship W2001003983A5055136911 @default.
- W2001003983 hasAuthorship W2001003983A5062126653 @default.
- W2001003983 hasAuthorship W2001003983A5064325537 @default.
- W2001003983 hasAuthorship W2001003983A5082664965 @default.
- W2001003983 hasConcept C118552586 @default.
- W2001003983 hasConcept C126322002 @default.
- W2001003983 hasConcept C151730666 @default.
- W2001003983 hasConcept C154945302 @default.
- W2001003983 hasConcept C15744967 @default.
- W2001003983 hasConcept C169760540 @default.
- W2001003983 hasConcept C176777502 @default.
- W2001003983 hasConcept C2776412080 @default.
- W2001003983 hasConcept C2778999636 @default.
- W2001003983 hasConcept C2779226451 @default.
- W2001003983 hasConcept C2779343474 @default.
- W2001003983 hasConcept C2780494398 @default.
- W2001003983 hasConcept C41008148 @default.